Assessment of left ventricular function after chemotherapy in breast cancer patients using ultrasonic vector flow mapping
|更新时间:2025-12-15
|
Assessment of left ventricular function after chemotherapy in breast cancer patients using ultrasonic vector flow mapping
“The latest research shows that ultrasonic VFM and LS2D-STI technology can help comprehensively evaluate the cardiotoxicity of anthracycline chemotherapy in breast cancer patients, and E/e 'combined with EL and CIR has important clinical value in evaluating the changes of left ventricular diastolic function.”
Hang WU, Sijia WANG, Lixue YIN, et al. Assessment of left ventricular function after chemotherapy in breast cancer patients using ultrasonic vector flow mapping[J]. Oncoradiology, 2025, 34(1): 37-46.
DOI:
Hang WU, Sijia WANG, Lixue YIN, et al. Assessment of left ventricular function after chemotherapy in breast cancer patients using ultrasonic vector flow mapping[J]. Oncoradiology, 2025, 34(1): 37-46. DOI: 10.19732/j.cnki.2096-6210.2025.01.006.
Assessment of left ventricular function after chemotherapy in breast cancer patients using ultrasonic vector flow mapping